Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yajing Yang

Showing results (81-90 of 101) with videos related to

Pageof 11
Sort By:
Journal of Cellular and Molecular Medicine|October 13, 2025
BNIP3L/BNIP3-Mediated Mitophagy Contributes to the Maintenance of Ovarian Cancer Stem CellsNa Li, Tejinder Pal Khaket, Yajing Yang, et al.
Cellular Oncology (Dordrecht, Netherlands)|July 14, 2025
S100A9 promotes resistance to anti-PD-1 immunotherapy in hepatocellular carcinoma by degrading PARP1 and activating the STAT3/PD-L1 pathwayXianwei Zhou, Chu Qiao, Xuehui Chu, et al.
Cancer Research|February 17, 2022
TET2 Suppresses VHL Deficiency-Driven Clear Cell Renal Cell Carcinoma by Inhibiting HIF SignalingXinchao Zhang, Shuyan Li, Jing He, et al.
Cell Discovery|September 22, 2023
Publisher Correction: TET2 is required to suppress mTORC1 signaling through urea cycle with therapeutic potentialJing He, Mingen Lin, Xinchao Zhang, et al.
Cell Discovery|August 7, 2023
TET2 is required to suppress mTORC1 signaling through urea cycle with therapeutic potentialJing He, Mingen Lin, Xinchao Zhang, et al.
Research (Washington, D.C.)|April 27, 2026
Myokine Cathepsin B as a Key Muscle-Brain Axis Regulator Mediates Treadmill-Running-Induced Hippocampal Neurogenesis and Cognitive Improvement in MiceXuchang Zhou, Dongxue Wang, Huili Deng, et al.
NPJ Precision Oncology|July 10, 2023
ALDH1A1 promotes PARP inhibitor resistance by enhancing retinoic acid receptor-mediated DNA polymerase θ expressionKousalya Lavudi, Ananya Banerjee, Na Li, et al.
Bioorganic & Medicinal Chemistry Letters|May 19, 2012
Discovery and optimization of a potent and selective triazolopyridinone series of c-Met inhibitorsChristiane M Bode, Alessandro A Boezio, Brian K Albrecht, et al.
The Journal of Biological Chemistry|December 7, 2007
c-Met inhibitors with novel binding mode show activity against several hereditary papillary renal cell carcinoma-related mutationsSteven F Bellon, Paula Kaplan-Lefko, Yajing Yang, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 2025
MTA-cooperative PRMT5 inhibitors from cofactor-directed DNA-encoded library screensJan Andersson, Sanne Cowland, Mikkel Vestergaard, et al.
Pageof 11

Showing results (81-90 of 101) with videos related to

Sort By:
Pageof 11
Journal of Cellular and Molecular Medicine|October 13, 2025
BNIP3L/BNIP3-Mediated Mitophagy Contributes to the Maintenance of Ovarian Cancer Stem CellsNa Li, Tejinder Pal Khaket, Yajing Yang, et al.
Cellular Oncology (Dordrecht, Netherlands)|July 14, 2025
S100A9 promotes resistance to anti-PD-1 immunotherapy in hepatocellular carcinoma by degrading PARP1 and activating the STAT3/PD-L1 pathwayXianwei Zhou, Chu Qiao, Xuehui Chu, et al.
Cancer Research|February 17, 2022
TET2 Suppresses VHL Deficiency-Driven Clear Cell Renal Cell Carcinoma by Inhibiting HIF SignalingXinchao Zhang, Shuyan Li, Jing He, et al.
Cell Discovery|September 22, 2023
Publisher Correction: TET2 is required to suppress mTORC1 signaling through urea cycle with therapeutic potentialJing He, Mingen Lin, Xinchao Zhang, et al.
Cell Discovery|August 7, 2023
TET2 is required to suppress mTORC1 signaling through urea cycle with therapeutic potentialJing He, Mingen Lin, Xinchao Zhang, et al.
Research (Washington, D.C.)|April 27, 2026
Myokine Cathepsin B as a Key Muscle-Brain Axis Regulator Mediates Treadmill-Running-Induced Hippocampal Neurogenesis and Cognitive Improvement in MiceXuchang Zhou, Dongxue Wang, Huili Deng, et al.
NPJ Precision Oncology|July 10, 2023
ALDH1A1 promotes PARP inhibitor resistance by enhancing retinoic acid receptor-mediated DNA polymerase θ expressionKousalya Lavudi, Ananya Banerjee, Na Li, et al.
Bioorganic & Medicinal Chemistry Letters|May 19, 2012
Discovery and optimization of a potent and selective triazolopyridinone series of c-Met inhibitorsChristiane M Bode, Alessandro A Boezio, Brian K Albrecht, et al.
The Journal of Biological Chemistry|December 7, 2007
c-Met inhibitors with novel binding mode show activity against several hereditary papillary renal cell carcinoma-related mutationsSteven F Bellon, Paula Kaplan-Lefko, Yajing Yang, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 2025
MTA-cooperative PRMT5 inhibitors from cofactor-directed DNA-encoded library screensJan Andersson, Sanne Cowland, Mikkel Vestergaard, et al.
Pageof 11